Seminars in Oncology
Volume 36 , Pages S52-S58 , April 2009

Role of c-Met in Cancer: Emphasis on Lung Cancer

  • Ravi Salgia

      Affiliations

    • Corresponding Author InformationAddress correspondence to Ravi Salgia, MD, PhD, Department of Medicine, University of Chicago, Pritzker School of Medicine, 5841 S Maryland Ave, Chicago, IL 60637

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Dr Salgia reports serving on the Scientific Advisory Board for Cephalon and Biogen Idec, and as a Consultant for Merck.

 This work in part is supported by the NIH/NCI (2R01CA100750-05A1, 5R01CA125541-03, 1R01CA129501-01A1, 2P01HL058064-13), MARF (Jefferey P. Hayes Memorial), Cancer Research Foundation (Goldblatt Award) and V-Foundation (Guy Geelerd Memorial Foundation).

PII: S0093-7754(09)00036-0

doi: 10.1053/j.seminoncol.2009.02.008

Seminars in Oncology
Volume 36 , Pages S52-S58 , April 2009

Article Tools

* Image Usage & Resolution